Physician profile
Thomas J Weber
NPI 1568522399
$36,779.69
in general payments reported to CMS, 2019-2025
48 companies · $2,209 in 2025
The $2,209 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,187 · 2020: $1,570 · 2021: $1,960 · 2022: $5,185 · 2023: $15K · 2024: $9,151 · 2025: $2,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Consulting Fee: $4,781 · Travel and Lodging: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,141.16 |
| Consulting Fee | $4,781.26 |
| Travel and Lodging | $1,955.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,707.35 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $5,611.70 | 2022-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Artisan |
| Nevro Corp. | $3,745.64 | 2019-2022 | |
| Biotronik Nro, INC. | $2,071.15 | 2023-2025 | Prospera, Biotronik |
| Collegium Pharmaceutical, INC. | $1,127.59 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $755.42 | 2021-2025 | Ubrelvy, Qulipta |
| Nalu Medical, INC. | $607.23 | 2021-2022 | |
| Globus Medical, INC. | $478.08 | 2020 | |
| Ibsa Pharma INC. | $452.65 | 2021-2025 | Licart, Tirosint, Tirosint |
| Medtronic, INC. | $367.65 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $366.81 | 2019-2023 | Ajovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $364.20 | 2019-2023 | Relistor |
| Vertos Medical, INC. | $350.64 | 2022-2024 | Mild Device Kit |
| Merz Pharmaceuticals, LLC | $326.52 | 2021-2025 | Xeomin |
| Lundbeck LLC | $321.65 | 2022-2025 | Vyepti |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $281.09 | 2021-2023 | Painteq |
| Forte Bio-Pharma LLC | $276.73 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Biodelivery Sciences International, INC. | $251.46 | 2019-2021 | |
| Pfizer INC. | $200.21 | 2021-2025 | |
| Amgen INC. | $198.54 | 2019-2022 | |
| Assertio Therapeutics, INC. | $183.38 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $181.08 | 2019-2024 | Ztlido |
| Sonex Health, INC. | $166.05 | 2023-2024 | Sx-One Microknife |
| Electronic Waveform Lab, INC. | $150.44 | 2019 | |
| Spr Therapeutics, INC | $130.22 | 2022-2023 | Sprint Pns System |
| Almatica Pharma LLC | $116.30 | 2022-2023 | Gralise |
| Stryker Corporation | $104.90 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $83.96 | 2023-2025 | Evoke Scs, Evoke |
| Arbor Pharmaceuticals, INC. | $83.69 | 2019-2021 | |
| Novo Nordisk INC | $83.62 | 2023-2024 | Wegovy |
| Sentynl Therapeutics, INC. | $72.38 | 2019 | |
| Si-Bone, INC. | $62.07 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $53.81 | 2024-2025 | |
| Grt US Holding, INC. | $49.82 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $49.63 | 2023 | Levorphanol Tartrate |
| Axsome Therapeutics, INC. | $41.50 | 2025 | Symbravo |
| Bioventus LLC | $39.74 | 2019-2022 | |
| Zyla Life Sciences, INC. | $38.26 | 2019 | |
| Mdd US Operations, LLC | $34.46 | 2019 | |
| Averitas Pharma INC. | $31.13 | 2023 | Qutenza |
| Avanos Medical | $24.71 | 2024 | Standard Rf Disposables |
| Novartis Pharmaceuticals Corporation | $24.11 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.94 | 2022 | |
| Masimo Corporation | $20.64 | 2023 | Patient Safetynet System |
| Merz North America, INC. | $20.49 | 2021 | |
| Protega Pharmaceutials INC | $19.41 | 2024 | Roxybond |
| Amneal Pharmaceuticals LLC | $16.59 | 2023 | Lyvispah |
| Kowa Pharmaceuticals America, INC. | $13.05 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.